American Medical Technologies Stock Probability Of Bankruptcy
American Medical's odds of distress is above 80% at the present time. It has very high probability of going through financial straits in the upcoming years. Probability of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the American balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
American |
American Medical Technologies Company probability of distress Analysis
American Medical's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current American Medical Probability Of Bankruptcy | Over 100% |
Most of American Medical's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, American Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of American Medical probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting American Medical odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of American Medical Technologies financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, American Medical Technologies has a Probability Of Bankruptcy of 100%. This is 131.0% higher than that of the Health Care Equipment & Supplies sector and 175.86% higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
American Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses American Medical's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of American Medical could also be used in its relative valuation, which is a method of valuing American Medical by comparing valuation metrics of similar companies.American Medical is currently under evaluation in probability of bankruptcy category among its peers.
American Fundamentals
| Return On Asset | -0.17 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 482.09 K | ||||
| Price To Sales | 0.0001 X | ||||
| Revenue | 2.5 M | ||||
| Gross Profit | 1.66 M | ||||
| EBITDA | (260.95 K) | ||||
| Net Income | 194.36 K | ||||
| Cash And Equivalents | 40.62 K | ||||
| Current Ratio | 0.47 X | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (160.42 K) | ||||
| Number Of Employees | 12 | ||||
| Beta | -38.54 | ||||
| Market Capitalization | 20.78 K | ||||
| Total Asset | 1.53 M | ||||
| Retained Earnings | (44.65 M) | ||||
| Working Capital | (1.1 M) | ||||
| Current Asset | 784 K | ||||
| Current Liabilities | 1.89 M | ||||
| Z Score | -39.6 | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 1.53 M |
About American Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze American Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of American Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of American Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in American Stock
If you are still planning to invest in American Medical Tec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the American Medical's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |